A Novel Approach for Quantifying GPCR Dimerization Equilibrium Using Bioluminescence Resonance Energy Transfer

Along with other resonance energy transfer techniques, bioluminescence resonance energy transfer (BRET) has emerged as an important method for demonstrating protein–protein interactions in cells. In the field of G protein-coupled receptors, including chemokine receptors, BRET has been widely used to investigate homo- and heterodimerization, a feature of their interactions that is emerging as integral to function and regulation. While demonstrating the existence of dimers for a given receptor proved to be fairly straightforward, quantitative comparisons of different receptors or mutants are nontrivial because of inevitable variations in the expression of receptor constructs. The uncontrollable parameters of the cellular expression machinery make amounts of transfected DNA extremely poor predictors for the expression levels of BRET donor and acceptor receptor constructs, even in relative terms. In this chapter, we show that properly accounting for receptor expression levels is critical for quantitative interpretation of BRET data. We also provide a comprehensive account of expected responses in all types of BRET experiments and propose a framework for uniform and accurate quantitative treatment of these responses. The framework allows analysis of both homodimer and heterodimer BRET data. The important caveats and obstacles for quantitative treatment are outlined, and the utility of the approach is illustrated by its application to the homodimerization of wild-type (WT) and mutant forms of the chemokine receptor CXCR4.

[1]  L. Pardo,et al.  Crystal structure of the μ-opioid receptor bound to a morphinan antagonist , 2012, Nature.

[2]  Bryan L. Roth,et al.  Structure of the human kappa opioid receptor in complex with JDTic , 2012, Nature.

[3]  M. Nieman,et al.  Mapping Human Protease-activated Receptor 4 (PAR4) Homodimer Interface to Transmembrane Helix 4* , 2012, The Journal of Biological Chemistry.

[4]  L. Drinovec,et al.  Quantitative Assessment of Seven Transmembrane Receptors (7TMRs) Oligomerization by Bioluminescence Resonance Energy Transfer (BRET) Technology , 2012 .

[5]  J. Selent,et al.  Oligomerization of G protein-coupled receptors: biochemical and biophysical methods. , 2011, Current medicinal chemistry.

[6]  R. Koenen,et al.  Heterophilic chemokine receptor interactions in chemokine signaling and biology. , 2011, Experimental cell research.

[7]  T. Kenakin Functional Selectivity and Biased Receptor Signaling , 2011, Journal of Pharmacology and Experimental Therapeutics.

[8]  K. Pfleger,et al.  Study of GPCR-protein interactions by BRET. , 2011, Methods in molecular biology.

[9]  L. Prézeau,et al.  Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to G protein-coupled receptor oligomerization. , 2011, Methods in molecular biology.

[10]  S. Marullo,et al.  Using quantitative BRET to assess G protein-coupled receptor homo- and heterodimerization. , 2011, Methods in molecular biology.

[11]  R. Abagyan,et al.  Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.

[12]  P. Sexton,et al.  Importance of lipid-exposed residues in transmembrane segment four for family B calcitonin receptor homo-dimerization , 2010, Regulatory Peptides.

[13]  J. Javitch,et al.  Time-resolved FRET between GPCR ligands reveals oligomers in native tissues. , 2010, Nature chemical biology.

[14]  F. Ciruela,et al.  Lighting up multiprotein complexes: lessons from GPCR oligomerization. , 2010, Trends in biotechnology.

[15]  George Khelashvili,et al.  GPCR-OKB: the G Protein Coupled Receptor Oligomer Knowledge Base , 2010, Bioinform..

[16]  L. Miller,et al.  Dimeric Arrangement of the Parathyroid Hormone Receptor and a Structural Mechanism for Ligand-induced Dissociation* , 2010, The Journal of Biological Chemistry.

[17]  R. Franco,et al.  Oligomerization of G-protein-coupled receptors: a reality. , 2010, Current opinion in pharmacology.

[18]  K. Pfleger,et al.  Recent advances in bioluminescence resonance energy transfer technologies to study GPCR heteromerization. , 2010, Current opinion in pharmacology.

[19]  Gregory I. Mashanov,et al.  Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules , 2010, Proceedings of the National Academy of Sciences.

[20]  M. Parmentier,et al.  Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the Protean Effects of “Selective” Antagonists* , 2009, The Journal of Biological Chemistry.

[21]  Ruben Abagyan,et al.  Functional Importance of a Structurally Distinct Homodimeric Complex of the Family B G Protein-Coupled Secretin Receptor , 2009, Molecular Pharmacology.

[22]  M. Robitaille,et al.  Novel tools for use in bioluminescence resonance energy transfer (BRET) assays. , 2009, Methods in molecular biology.

[23]  T. Handel,et al.  Modulation of chemokine receptor activity through dimerization and crosstalk , 2009, Cellular and Molecular Life Sciences.

[24]  L. Miller,et al.  Dimerization in the absence of higher-order oligomerization of the G protein-coupled secretin receptor. , 2008, Biochimica et biophysica acta.

[25]  Tullio Pozzan,et al.  CXCR4–CCR5: A couple modulating T cell functions , 2008, Proceedings of the National Academy of Sciences.

[26]  F. Baleux,et al.  CXCR4 dimerization and beta-arrestin-mediated signaling account for the enhanced chemotaxis to CXCL12 in WHIM syndrome. , 2008, Blood.

[27]  V. Gurevich,et al.  GPCR monomers and oligomers: it takes all kinds , 2008, Trends in Neurosciences.

[28]  L. Miller,et al.  Transmembrane Segment IV Contributes a Functionally Important Interface for Oligomerization of the Class II G Protein-coupled Secretin Receptor* , 2007, Journal of Biological Chemistry.

[29]  Marc Parmentier,et al.  Allosteric Transinhibition by Specific Antagonists in CCR2/CXCR4 Heterodimers* , 2007, Journal of Biological Chemistry.

[30]  S. Marullo,et al.  Resonance energy transfer approaches in molecular pharmacology and beyond. , 2007, Trends in pharmacological sciences.

[31]  A. Salahpour,et al.  Experimental challenge to a 'rigorous' BRET analysis of GPCR oligomerization , 2007, Nature Methods.

[32]  Michel Bouvier,et al.  Requirements and ontology for a G protein-coupled receptor oligomerization knowledge base , 2007, BMC Bioinformatics.

[33]  D. Oprian,et al.  Transducin Activation by Nanoscale Lipid Bilayers Containing One and Two Rhodopsins* , 2007, Journal of Biological Chemistry.

[34]  Richard N. Zare,et al.  A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein , 2007, Proceedings of the National Academy of Sciences.

[35]  Andrea Iaboni,et al.  A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer , 2006, Nature Methods.

[36]  C. Combs,et al.  Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions , 2006, Molecular Cancer Therapeutics.

[37]  K. Eidne,et al.  Illuminating insights into protein-protein interactions using bioluminescence resonance energy transfer (BRET) , 2006, Nature Methods.

[38]  T. Issad,et al.  Bioluminescence resonance energy transfer to monitor protein-protein interactions. , 2006, Methods in molecular biology.

[39]  Marc Parmentier,et al.  Dimerization of chemokine receptors and its functional consequences. , 2005, Cytokine & growth factor reviews.

[40]  Michel Bouvier,et al.  Methods to monitor the quaternary structure of G protein‐coupled receptors , 2005, The FEBS journal.

[41]  Mario Mellado,et al.  Response to "On the dimerization of CCR5" , 2005, Nature Immunology.

[42]  S. Marullo,et al.  On the dimerization of CCR5 , 2005, Nature Immunology.

[43]  Michel Bouvier,et al.  Bioluminescence Resonance Energy Transfer Reveals Ligand-induced Conformational Changes in CXCR4 Homo- and Heterodimers* , 2005, Journal of Biological Chemistry.

[44]  Alain Dupuy,et al.  WHIM syndromes with different genetic anomalies are accounted for by impaired CXCR4 desensitization to CXCL12. , 2005, Blood.

[45]  Michel Bouvier,et al.  Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. , 2005, Trends in pharmacological sciences.

[46]  M. Parmentier,et al.  Evidence for Negative Binding Cooperativity within CCR5-CCR2b Heterodimers , 2005, Molecular Pharmacology.

[47]  Graeme Milligan,et al.  G Protein-Coupled Receptor Dimerization: Function and Ligand Pharmacology , 2004, Molecular Pharmacology.

[48]  Alfonso Valencia,et al.  Identification of amino acid residues crucial for chemokine receptor dimerization , 2004, Nature Immunology.

[49]  M. Bouvier,et al.  Roles of G‐protein‐coupled receptor dimerization , 2004, EMBO reports.

[50]  R. Gorlin,et al.  Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease , 2003, Nature Genetics.

[51]  Michel Bouvier,et al.  Constitutive Agonist-independent CCR5 Oligomerization and Antibody-mediated Clustering Occurring at Physiological Levels of Receptors* 210 , 2002, The Journal of Biological Chemistry.

[52]  T. Issad,et al.  The use of resonance energy transfer in high-throughput screening: BRET versus FRET. , 2002, Trends in pharmacological sciences.

[53]  Michel Bouvier,et al.  Dimerization: an emerging concept for G protein-coupled receptor ontogeny and function. , 2002, Annual review of pharmacology and toxicology.

[54]  R. Tsien,et al.  Reducing the Environmental Sensitivity of Yellow Fluorescent Protein , 2001, The Journal of Biological Chemistry.

[55]  Mario Mellado,et al.  Chemokine receptor homo‐ or heterodimerization activates distinct signaling pathways , 2001, The EMBO journal.

[56]  Richard N. Day,et al.  Fluorescent protein spectra. , 2001, Journal of cell science.

[57]  G. Milligan,et al.  Ligand regulation of green fluorescent protein-tagged forms of the human beta(1)- and beta(2)-adrenoceptors; comparisons with the unmodified receptors. , 2000, British journal of pharmacology.

[58]  Charles R. Gerfen,et al.  Current Protocols In Neuroscience , 1999 .

[59]  R. Doms,et al.  An Intricate Web: Chemokine Receptors, HIV‐1 and Hematopoiesis , 1998, Stem cells.

[60]  Kuan-Teh Jeang,et al.  Mechanism of Transdominant Inhibition of CCR5-mediated HIV-1 Infection by ccr5Δ32* , 1997, The Journal of Biological Chemistry.

[61]  Richard A Koup,et al.  Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection , 1996, Cell.

[62]  L. Stryer,et al.  The dimeric nature of the gramicidin A transmembrane channel: conductance and fluorescence energy transfer studies of hybrid channels. , 1977, Journal of molecular biology.